Tag: 17p

US nod for Venclexta/Rituxan combo

by Selina McKee | Jun 11, 2018 | News | 0

US regulators have approved a combination of AbbVie and Roche’s Venclexta in combination with Roche/Biogen’s Rituxan (rituximab) to treat chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).

AbbVie’s Venclyxto OK’d in Europe for CLL

by Selina McKee | Dec 8, 2016 | News | 0

Patients with difficult to treat forms of chronic lymphocytic leukaemia (CLL) have gained a new treatment option after the European Commission issued a green light for AbbVie’s Venclyxto.